Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome

Table 3

Patients, timing of injections, and residual edema in OCT-1 injection group.

	1 injection within 1 month	1 injection within 2 months	1 injection within 3 months	1 injection after more than 3 months
No. of patients	12	6	5	6
No. of patients with residual edema in OCT	2	1	2	4